RetractedArticleBlood2009

Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.

Rachel M A Linger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.